SOPHiA GENETICS SA (NASDAQ:SOPH) Q2 2024 Earnings Conference Call August 6, 2024 8:00 AM ET

Company Participants

Kellen Sanger - Head of Strategy and Investor Relations
Jurgi Camblong - Co-Founder and Chief Executive Officer
Ross Muken - Chief Financial Officer and Chief Operating Officer.

Conference Call Participants

Dan Brennan - TD Cowen
Subbu Nambi - Guggenheim
Conor McNamara - RBC Capital Markets
Tejas Savant - Morgan Stanley

Operator

Good morning. My name is Kevin and I'll be your conference operator for today. At this time, I'd like to welcome everyone to the SOPHiA GENETICS Second Quarter 2024 Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being recorded on Tuesday, August 6, 2024.

I would now like to turn the call over to Kellen Sanger, SOPHiA GENETICS' Head of Strategy and Investor Relations. Please go ahead.

Kellen Sanger

Thank you and good morning, everyone. Welcome to the SOPHiA GENETICS second quarter 2024 earnings conference call. Joining me today to discuss our results are Dr. Jurgi Camblong, our Co-Founder and Chief Executive Officer; and Ross Muken, our Chief Financial Officer and Chief Operating Officer.

I'd like to remind you that management will make statements during this call that are forward-looking statements within the meanings of Federal Securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements.

Additional information regarding these risks, uncertainties and factors that could cause results to differ appears in the press release of SOPHiA GENETICS issued today and in the documents and reports filed by SOPHiA GENETICS from time to time with the Securities and Exchange Commission.

During this call, we will present both IFRS and non-IFRS financial measures. A reconciliation of IFRS to non-IFRS measures is included in today's earnings press release, which is available on our website.

With that, I'll now turn the call over to Jurgi.

Jurgi Camblong

Thanks, Kellen, and good morning, everyone.

In Q2, we delivered another quarter of strong forward-looking indicators and continued bottom-line improvements despite facing macro challenges, which have temporarily softened revenue growth.

I will start the call by discussing the challenges we faced, and a few of the growth initiatives we accelerated to offset disadvantages. Next, I will highlight how these initiatives have positioned us well to re-accelerate growth by later this year. Last, I will provide a brief update on our path to adjusted operating profitability, which remains on track as we manage costs well and improve our bottom line. I will then turn the call over to Ross, who will give you a closer look at our Q2 financials, our updated outlook for 2024 and additional details regarding our path to profitability.